We are live on ! Find out more
NVCR icon

NovoCure
NVCR

Fund managers haven’t disclosed any holdings of NVCR yet.

NVCR Hedge Fund Activity: Q1 2026 in Review

222 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q1 2026, worth a combined $1.08B — down 13% from $1.24B a quarter earlier.

Sellers outnumbered buyers: 49 funds closed out of NVCR and 38 opened new positions — a net loss of 11 holders — while 75 trimmed existing stakes and 76 added.

The largest buyer was Wells Fargo, adding an estimated $35.1M. The largest seller was American Century Companies, cutting an estimated $10.5M.

  • 222 institutional investors held NovoCure (NVCR) as of Q1 2026, down from 238 in Q4 2025.
  • Funds reported $1.08B of NovoCure stock for Q1 2026, down 13% quarter-over-quarter.
  • 38 funds opened new NovoCure positions in Q1 2026 and 49 closed out, a net change of -11 holders.
  • The largest NovoCure buyer in Q1 2026 was Wells Fargo, an estimated $35.1M added.
  • The largest NovoCure seller in Q1 2026 was American Century Companies, an estimated $10.5M sold.

Based on aggregated 13F filings for Q1 2026.